SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-15-406986
Filing Date
2015-12-18
Accepted
2015-12-18 07:48:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d107171dsctota.htm SC TO-T/A 30715
2 EX-99.(A)(1)(J) d107171dex99a1j.htm EX-99.(A)(1)(J) 12755
3 GRAPHIC g107171g10j44.jpg GRAPHIC 16030
  Complete submission text file 0001193125-15-406986.txt   67309
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Subject) CIK: 0001140098 (see all company filings)

IRS No.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-79462 | Film No.: 151295256
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411
Business Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T/A